Treatment of refractory multiple myeloma and considerations for future therapy

"Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma-the Mayo Clinic experience.

Blood cancer journal·2021

Systemic amyloidosis from A (AA) to T (ATTR): a review.

Journal of internal medicine·2020

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Leukemia·2019

Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Leukemia·2017

Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.

Bone marrow transplantation·2017

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains.

Leukemia·2017

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Seminars in oncology·2026

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Seminars in oncology·2026

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Seminars in oncology·2026

Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case report.

Seminars in oncology·2026

Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challenges.

Seminars in oncology·2026

A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000-2026): advances in molecular mechanisms and therapeutic strategies.

Seminars in oncology·2026

Progress in Synthesis and Pharmacology of Telmisartan.

Chemistry & biodiversity·2026

Functional psychosurgery in psychiatry: indications and preoperative evaluation. A narrative review.

Frontiers in psychiatry·2026

Development of humanized mouse models for the preclinical evaluation of NK cell-based therapies.

Frontiers in immunology·2026

Focused Ultrasound is Poised to Take Non-Viral Gene Therapies to the Blood-Brain Barrier - and Beyond.

Cell biomaterials·2026

pAc/Emm55 increases anti-melanoma immunity via TLR2 signaling in dendritic cells and improves checkpoint blockade efficacy.

Frontiers in immunology·2026

Exposure-response and dose simulation of belantamab mafodotin in combination with standards of care in patients with relapsed/refractory multiple myeloma.

Haematologica·2026

Related Experiment Videos

Treatment of refractory multiple myeloma and considerations for future therapy

Related Concept Videos

"Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma-the Mayo Clinic experience.

Systemic amyloidosis from A (AA) to T (ATTR): a review.

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains.

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case report.

Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challenges.

A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000-2026): advances in molecular mechanisms and therapeutic strategies.

Progress in Synthesis and Pharmacology of Telmisartan.

Functional psychosurgery in psychiatry: indications and preoperative evaluation. A narrative review.

Development of humanized mouse models for the preclinical evaluation of NK cell-based therapies.

Focused Ultrasound is Poised to Take Non-Viral Gene Therapies to the Blood-Brain Barrier - and Beyond.

pAc/Emm55 increases anti-melanoma immunity via TLR2 signaling in dendritic cells and improves checkpoint blockade efficacy.

Exposure-response and dose simulation of belantamab mafodotin in combination with standards of care in patients with relapsed/refractory multiple myeloma.

Related Experiment Videos

Treatment of refractory multiple myeloma and considerations for future therapy

Related Concept Videos

Related Articles